z-logo
open-access-imgOpen Access
Efficacy and Safety of Zanubrutinib in IgA-secerning Lymphoplasmacytic Lymphoma
Author(s) -
Giulia Zamprogna,
Anna Maria Frustaci,
Marina Deodato,
Heather Allewelt,
Dirk Weber,
Claudia Rigamonti,
Alessandra Tedeschi
Publication year - 2022
Publication title -
journal of cancer science and clinical therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2637-5079
DOI - 10.26502/jcsct.5079151
Subject(s) - lymphoplasmacytic lymphoma , medicine , waldenstrom macroglobulinemia , lymphoma , ibrutinib , radiation therapy , chemotherapy , oncology , cancer research , chronic lymphocytic leukemia , leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom